Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 

Click here to go back to your search results.

Prostate Cancer treatment details. Hormone. Netherlands Cancer Institute, Amsterdam, Netherlands



Survival: 7.3 months
   
Toxicity Grade: 5
   
Treatments: Hormone
   
Drugs:
Country: Netherlands
   
City/State/Province: Amsterdam
   
Hospital: Netherlands Cancer Institute
   
Journal: Link
   
Date: 4/2014

Description:
Patients:
This study involved 61 metastatic, castrate-resistant prostate cancer patients who previously received docetaxel and abiraterone acetate. The median patient age was 69 years.

Treatment:
Patients received hormone therapy with enzalutamide.

Toxicities:
There was one reported study-related death due to stroke. Grade 3 fatigue and musculoskeletal pain were also reported.

Results:
The median overall survival was 7.3 months.

Correspondence: Dr. Andries M. Bergman; email: a.bergman@nki.nl

E-mail to a Friend Email Physician More Information